
CellaVision AB
STO:CEVI

CellaVision AB?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
Energy
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
149
296.5
|
Price Target |
|
We'll email you a reminder when the closing price reaches SEK.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.

What unique competitive advantages
does CellaVision AB hold over its rivals?
What risks and challenges
does CellaVision AB face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of CellaVision AB.
Provide an overview of the primary business activities
of CellaVision AB.
What unique competitive advantages
does CellaVision AB hold over its rivals?
What risks and challenges
does CellaVision AB face in the near future?
Has there been any significant insider trading activity
in CellaVision AB recently?
Summarize the latest earnings call
of CellaVision AB.
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for CellaVision AB.
Provide P/S
for CellaVision AB.
Provide P/E
for CellaVision AB.
Provide P/OCF
for CellaVision AB.
Provide P/FCFE
for CellaVision AB.
Provide P/B
for CellaVision AB.
Provide EV/S
for CellaVision AB.
Provide EV/GP
for CellaVision AB.
Provide EV/EBITDA
for CellaVision AB.
Provide EV/EBIT
for CellaVision AB.
Provide EV/OCF
for CellaVision AB.
Provide EV/FCFF
for CellaVision AB.
Provide EV/IC
for CellaVision AB.
Show me price targets
for CellaVision AB made by professional analysts.
What are the Revenue projections
for CellaVision AB?
How accurate were the past Revenue estimates
for CellaVision AB?
What are the Net Income projections
for CellaVision AB?
How accurate were the past Net Income estimates
for CellaVision AB?
What are the EPS projections
for CellaVision AB?
How accurate were the past EPS estimates
for CellaVision AB?
What are the EBIT projections
for CellaVision AB?
How accurate were the past EBIT estimates
for CellaVision AB?
Compare the revenue forecasts
for CellaVision AB with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of CellaVision AB and its key competitors using the latest financial data.
Compare historical revenue growth rates
of CellaVision AB against its competitors.
Analyze the profit margins
(gross, operating, and net) of CellaVision AB compared to its peers.
Compare the P/E ratios
of CellaVision AB against its peers.
Discuss the investment returns and shareholder value creation
comparing CellaVision AB with its peers.
Analyze the financial leverage
of CellaVision AB compared to its main competitors.
Show all profitability ratios
for CellaVision AB.
Provide ROE
for CellaVision AB.
Provide ROA
for CellaVision AB.
Provide ROIC
for CellaVision AB.
Provide ROCE
for CellaVision AB.
Provide Gross Margin
for CellaVision AB.
Provide Operating Margin
for CellaVision AB.
Provide Net Margin
for CellaVision AB.
Provide FCF Margin
for CellaVision AB.
Show all solvency ratios
for CellaVision AB.
Provide D/E Ratio
for CellaVision AB.
Provide D/A Ratio
for CellaVision AB.
Provide Interest Coverage Ratio
for CellaVision AB.
Provide Altman Z-Score Ratio
for CellaVision AB.
Provide Quick Ratio
for CellaVision AB.
Provide Current Ratio
for CellaVision AB.
Provide Cash Ratio
for CellaVision AB.
What is the historical Revenue growth
over the last 5 years for CellaVision AB?
What is the historical Net Income growth
over the last 5 years for CellaVision AB?
What is the current Free Cash Flow
of CellaVision AB?
Discuss the annual earnings per share (EPS)
trend over the past five years for CellaVision AB.
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
Market Cap | EV/EBITDA | ||||
---|---|---|---|---|---|
SE |
![]() |
CellaVision AB
STO:CEVI
|
4.6B SEK | 22.8 | |
US |
![]() |
Abbott Laboratories
NYSE:ABT
|
231.3B USD | 22.2 |
|
US |
![]() |
Intuitive Surgical Inc
NASDAQ:ISRG
|
198B USD | 64.5 |
|
US |
![]() |
Boston Scientific Corp
NYSE:BSX
|
155.7B USD | 36.1 |
|
US |
![]() |
Stryker Corp
NYSE:SYK
|
146.2B USD | 25.3 |
|
IE |
![]() |
Medtronic PLC
NYSE:MDT
|
106.4B USD | 12.8 |
|
DE |
![]() |
Siemens Healthineers AG
XETRA:SHL
|
52.2B EUR | 14 |
|
US |
![]() |
Becton Dickinson and Co
NYSE:BDX
|
49.5B USD | 13 |
|
US |
![]() |
Edwards Lifesciences Corp
NYSE:EW
|
46B USD | 25.2 |
|
US |
![]() |
IDEXX Laboratories Inc
NASDAQ:IDXX
|
41.4B USD | 32.9 |
|
CN |
![]() |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
273.9B CNY | 21.5 |
|
EBITDA Growth | EV/EBITDA to Growth | |||||
---|---|---|---|---|---|---|
SE |
![]() |
CellaVision AB
STO:CEVI
|
Average EV/EBITDA:
26.4
22.8
|
18%
|
1.3 | |
US |
![]() |
Abbott Laboratories
NYSE:ABT
|
22.2
|
13%
|
1.7 |
|
US |
![]() |
Intuitive Surgical Inc
NASDAQ:ISRG
|
64.5
|
24%
|
2.7 |
|
US |
![]() |
Boston Scientific Corp
NYSE:BSX
|
36.1
|
21%
|
1.7 |
|
US |
![]() |
Stryker Corp
NYSE:SYK
|
25.3
|
12%
|
2.1 |
|
IE |
![]() |
Medtronic PLC
NYSE:MDT
|
12.8
|
5%
|
2.6 |
|
DE |
![]() |
Siemens Healthineers AG
XETRA:SHL
|
14
|
14%
|
1 |
|
US |
![]() |
Becton Dickinson and Co
NYSE:BDX
|
13
|
11%
|
1.2 |
|
US |
![]() |
Edwards Lifesciences Corp
NYSE:EW
|
25.2
|
12%
|
2.1 |
|
US |
![]() |
IDEXX Laboratories Inc
NASDAQ:IDXX
|
32.9
|
12%
|
2.7 |
|
CN |
![]() |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
21.5
|
16%
|
1.3 |
|
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.